Skip to Content
Advanced Search
Home > North America > USA > Opexa Therapeutics, Inc.

< Previous | Next >

Opexa Therapeutics, Inc. (Visit their Website)



Company Information

• Country: USA
• State or province: Texas
• Zip, postal code: 77381
• Telephone: 281-272-9331
• Fax: 281-272-1088
• Street Address: 2635 N. Crescent Ridge Drive The Woodlands
 • Ceo, President: Neil K. Warma

Summary

Opexa Therapeutics is a biotechnology company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes. The company’s product candidates have the potential to offer enhanced efficacy, safety and tolerability to address the significant unmet medical needs in several large patient populations
Visit Opexa Therapeutics, Inc..

Description (Web site quote)

Opexa's lead product candidate is Tovaxin, a novel T-cell vaccine for the treatment of MS that is specifically tailored to each patient's disease profile. Opexa believes the potential combination of efficacy, superior safety, improved tolerability and administration may position Tovaxin as the MS treatment of choice as compared to existing therapeutic options.

Top-line results from the Phase IIb Tovaxin for Early Relapsing Multiple Sclerosis (TERMS) study demonstrated a positive trend in reduction in annualized relapse rate for Tovaxin-treated patients as compared to placebo, as well as an excellent safety profile with no serious adverse events related to Tovaxin treatment.


Visit Opexa Therapeutics, Inc..

Opexa Therapeutics is a biotechnology company dedicated to the development of patient-specific cellular therapies for the treatment of autoimmune diseases such as multiple sclerosis (MS) and diabetes. The company’s product candidates have the potential to offer enhanced efficacy, safety and tolerability to address the significant unmet medical needs in several large patient populations

Submitted by: admin
Hits: 41
Added: Sun Jan 17 2010